Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumors

Overview of attention for article published in Investigational New Drugs, June 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 64 Dimensions

Readers on

mendeley: 57 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Methods of treatment using N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propo…

Grant US-9567358-B2

United States of America

Phosphonoxy quinazoline derivatives and their pharmaceutical use

Grant US-9018191-B2

United States of America